Heal, a company that allows patients to book physician house calls through an app-driven digital scheduling and processing platform, announced this morning that it has raised $20 million in new investment capital, bringing the company’s raised total to more than $69 million.
Treating the opioid epidemic has challenged researchers and providers for years. Looking at patient adherence — both to opioid substitutes and painkillers — has been an avenue several companies have begun to look at.
Patient-provider communication platform Luma Health has just announced that it landed $6.3 million in a Series A funding round led by U.S Venture Partners with participation from Stanford-StartX Fund and existing investors, bring the total financing to $9.7 million.
FCC commissioners united on telemedicine. In an editorial in the Boston Globe yesterday, FCC Commissioner Ajit Pai and former commissioner Newton N. Minow presented a unified front on the importance of rural telemedicine.
Cambridge, Massachusetts-based Iora Health, a digitally-enabled primary care provider that focuses on the senior Medicare population, announced yesterday that it has closed $100 million in Series E financing. This brings the company’s total funding to at least $223.5 million.
Specialty pharmaceuticals are all different, but there’s one thing they have in common: they are difficult to prescribe. Whether it’s because of high cost, high risk, narrow therapeutic range, or complicated dosing, these drugs require would-be prescribing physicians to prove to insurers the drug is the right choice for their patient by filling out a number of forms and providing key data about the patient.
Home care technology company Honor has brought in $50 million in Series C financing, the company announced this morning, bringing the company’s total funding to $115 million. The funding round was led by Naspers Ventures, with additional participation from existing investors Thrive Capital and Andreessen Horowitz.
San Francisco-based Hinge Health has completed a randomized control trial of its digital care program for chronic knee pain. Results were promising, with users of the digital platform outperforming the control group in every outcome measure, though there was some loss of engagement among the study group.
In the past checking your blood pressure generally meant a trip to the doctor's office—or at least a pharmacy. But that could be changing.
Eye telemedicine company Simple Contacts announced it raked in $16 million in Series B funding at the end of last week. The latest round, which was led by Waypoint Capital Partners with participation from returning investors Goodwater Capital, Steven Cohen, executives from Flatiron Health and a number of ophthalmologists, brings the company’s total funding to $26 million.